Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.
作者信息
Hawkey C J
机构信息
Division of Gastroenterology, University Hospital, Nottingham.
出版信息
BMJ. 1994 Dec 10;309(6968):1570-1. doi: 10.1136/bmj.309.6968.1570.
Abstract
摘要
相似文献
1
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.
BMJ. 1994 Dec 10;309(6968):1570-1. doi: 10.1136/bmj.309.6968.1570.
2
Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Helicobacter pylori is not the causative agent.
BMJ. 1994 Dec 10;309(6968):1571-2. doi: 10.1136/bmj.309.6968.1571.
3
[Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
Gastroenterol Hepatol. 2005 Nov;28(9):567-75. doi: 10.1157/13080605.
4
Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
Hepatogastroenterology. 1992 Feb;39 Suppl 1:40-4.
5
Peptic ulcer disease: what is the role for Helicobacter pylori?
Semin Gastrointest Dis. 1994 Jan;5(1):24-31.
6
Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
J Gastroenterol Hepatol. 2006 Jun;21(6):1048-53. doi: 10.1111/j.1440-1746.2005.04038.x.
7
Helicobacter pylori and gastrointestinal disease.
J Clin Pharmacol. 1995 Jul;35(7):647-54. doi: 10.1002/j.1552-4604.1995.tb04103.x.
8
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S35-8.
9
Modern management of peptic ulcer.
Practitioner. 1992 Oct;236(1519):956-61.
10
[Peptic ulcer recurrent in patients following successful eradication of Helicobacter pylori].
Nihon Rinsho. 2005 Nov;63 Suppl 11:508-11.
引用本文的文献
1
Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Pharmacoeconomics. 1999 Oct;16(4):355-65. doi: 10.2165/00019053-199916040-00004.
2
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
Pharmacoeconomics. 1996 Jul;10(1):79-92. doi: 10.2165/00019053-199610010-00008.
3
Why is mortality higher in poorer areas and in more northern areas of England and Wales?
J Epidemiol Community Health. 1998 Jun;52(6):344-52. doi: 10.1136/jech.52.6.344.
4
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
Gut. 1997 Oct;41(4):459-62. doi: 10.1136/gut.41.4.459.
5
Eradication of Helicobacter pylori in management of peptic ulceration. Evidence supports eradication only in patients who have helicobacter and peptic ulceration.
BMJ. 1995 Feb 25;310(6978):531. doi: 10.1136/bmj.310.6978.531.
6
Eradication of Helicobacter pylori in management of peptic ulceration. Gastric metaplasia should be considered too.
BMJ. 1995 Feb 25;310(6978):531. doi: 10.1136/bmj.310.6978.531a.
本文引用的文献
1
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Gastroenterology. 1993 May;104(5):1356-70. doi: 10.1016/0016-5085(93)90344-c.
2
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
N Engl J Med. 1993 Feb 4;328(5):308-12. doi: 10.1056/NEJM199302043280503.
3
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Scand J Gastroenterol. 1993 Nov;28(11):939-42. doi: 10.3109/00365529309098288.
4
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors.
Gut. 1994 Mar;35(3):309-12. doi: 10.1136/gut.35.3.309.
5
Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.
Aliment Pharmacol Ther. 1994 Aug;8(4):359-68. doi: 10.1111/j.1365-2036.1994.tb00303.x.
6
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Lancet. 1994 Feb 26;343(8896):508-10. doi: 10.1016/s0140-6736(94)91460-5.
7
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection.
BMJ. 1994 Jan 15;308(6922):176. doi: 10.1136/bmj.308.6922.176.
8
Attempt to fulfil Koch's postulates for pyloric Campylobacter.
Med J Aust. 1985 Apr 15;142(8):436-9. doi: 10.5694/j.1326-5377.1985.tb113443.x.
9
Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients.
Scand J Gastroenterol. 1990 Oct;25(10):966-73. doi: 10.3109/00365529008997621.
10
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study.
Scand J Gastroenterol. 1991 Oct;26(10):1057-65. doi: 10.3109/00365529109003956.
Zotero 插件